Pharmafile Logo
Pharmafocus logo
Advanced Search

New customers: new education

February 16, 2005

Doctors have for a long time been the primary influencers of prescribing and chronic disease management. For pharma companies, that …

Feature

NHS to be key election issue as Blair unveils pledge

February 15, 2005
Blair, NHS

 Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …

News

Chronic disease programme needs more work, says think tank

February 14, 2005

The new system of chronic disease management currently being piloted in ten PCTs needs further evaluation before it is extended …

News

Reid admits hospital closures a possibility

February 14, 2005

News

Trusts rewarded for hitting A&E targets

February 14, 2005

News

New UK biotech fundraising initiative declared a win-win

February 10, 2005
Research and Development

Current rules which restrict how companies raise cash should be interpreted more freely to help UK biotech and other hi-tech …

News

More money for PCTs in poor areas

February 9, 2005

News

Roche hepatitis and HIV combination approved

February 9, 2005
Sales and Marketing

Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …

News

Sanofi-Aventis sponsor cardiovascular research centre

February 9, 2005
Sales and Marketing

A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …

News

Schering launches new dermatology company

February 8, 2005
Sales and Marketing

German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …

News

Audit service launched to judge pharma marketing success

February 8, 2005

Marketing consultants Q2 Audit have launched a service to measure pharma's marketing effectiveness and give an indication of future product …

News

Rare side-effect warnings for Strattera

February 8, 2005
Sales and Marketing

UK health professionals have been warned  about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …

News

Connecting with patients

February 8, 2005
Medical Communications

In order for a clinical trial to be viable, it needs patients. Sounds obvious, but despite the fact that patients …

Feature

New depression treatment launched in the UK

February 3, 2005
Sales and Marketing

Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …

News

New ‘economic damage’ offence to beat animal activists

February 3, 2005
Sales and Marketing

The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …

News

‘Smarter steroid’ Alvesco launched in the UK

February 3, 2005
Sales and Marketing

Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …

News

Aspirin plus PPI better than Plavix in patients with GI bleed

February 2, 2005
Sales and Marketing

A new study has concluded that aspirin plus a proton pump inhibitor (PPI) is more effective than Plavix (clopidogrel) in …

News

BMJ apologises for Prozac accusations

February 2, 2005
Sales and Marketing

The BMJ has retracted its allegations that Eli Lilly suppressed important safety information on its antidepressant drug Prozac during litigation …

News

AstraZeneca remains strong despite setbacks

February 1, 2005
Sales and Marketing

AstraZeneca has announced impressive full-year figures for 2004 despite its market value slumping by nearly a third in the past …

News

Merck hit by US patent blow

February 1, 2005
Sales and Marketing

Merck has lost 10 years of US patent protection for the best-selling formulation of its second-biggest selling drug, following a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025